The COVID-19 outbreak in December 2019 resulting from the human coronavirus SARS-CoV-2 has been spreading rapidly throughout the world and has impacted the daily lives of hundreds of millions of people worldwide. Academic and applied scientists, healthcare providers, and support professionals globally have been showing unprecedented unity in sharing information, as well as providing support to the discovery and development of vaccines and anti-viral therapeutics.
Because infectious disease research deals with a wide range of viral, bacterial, and fungal pathogens, it demands analytical instruments that are precise but also versatile. PerkinElmer offers a product portfolio that meets the needs of many applications for infectious disease detection and research across your workflow.
PerkinElmer life science solutions (For Research Only) have enabled virus studies and continue to support associated workflows from early stages in deciphering the virus infection life cycle through understanding the basis of viral pathogenesis. The research solutions we offer include robotic laboratory automation systems that can integrate liquid handling with molecular and biomarker sample preparation from biological sources, including complex matrices, for the detection of viruses, and viral and host markers at both the genomic and proteomic level.
Identification of the most prevalent pathogens using next generation sequencing (NGS) allows researchers to collect population-level data to ensure the selection of antigens for the development of vaccines that can be used globally. When developing vaccines against pathogens, like SARS-CoV-2, detection methodologies are needed to analyze the efficacy of potential solutions. PerkinElmer offers real time RT-PCR assays, immunoassays, and next generation sequencing-based solutions to meet all of your SARS-CoV-2 detection needs.
To further understand the pathogenesis of viral infection and host immune responses, PerkinElmer’s high throughput screening and imaging platforms are designed to enable the detection, characterization, visualization, and quantitation of virus and host biomarkers and associated workflows in therapeutics discovery and development.
Our analytical technology platforms such as the Triple quadrupole LC/MS/MS and molecular spectrometers can be used in anti-viral drug and vaccine preclinical development stages through manufacturing and QA/QC of the final product.
PerkinElmer’s informatics solutions, including data science expertise, can assist pharma, biopharma, CRO, and academic research laboratories with managing data for the discovery and development of new and repurposing drugs as well as supporting clinical trial data.
